Our data suggest that PSMD1 and PSMD3 are upregulated upon CML disease progression and regulate NF-κB protein expression, transcriptional activity, and cell growth. This evidence concerns the gene PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive.